LGALS1 and neoplasm: Galectin-1 and galectin-3 tumors enhance adaptation to the hypoxic microenvironment by promoting angiogenesis, conversion of tumor cell metabolism to glycolysis, and tumor cell adaptation to metabolic stress [105,106].